Purchase Order 75N95023P00548
Award Date
8/11/23
Potential Completion Date
8/10/24
Potential Value
Not listed
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
Eurofins Discoverx Products, LLC
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Fremont, CA 94538, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awarded a firm-fixed-price purchase order valued at $20,787.00 to Eurofins Discoverx Corporation, a foreign-owned for-profit organization. The contract is for the provision of the PATHHUNTER CHO-K1 DRD2L (LONG ISOFORM) ARRESTIN cell line, which is used in drug discovery and development research. Eurofins Discoverx is a leading provider of innovative cell-based...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a firm-fixed-price purchase order to Eurofins Discoverx Products, LLC, a foreign-owned, self-certified small disadvantaged business, for a PathHunter Detection Kit. The potential value of the contract is $30,778.40, with a completion date of August 25, 2021. The services provided under this contract appear to be in support of the agency's mission of advancing...
This federal contract award to Eurofins Discoverx Corporation, a foreign-owned for-profit organization, is for the provision of specialized cell-based assays, reagents, and services to support drug discovery and research. The $13,482.10 firm fixed-price purchase order was awarded by the Midwest Area of the U.S. Department of Health and Human Services, which includes agencies such as the National Institutes of Health (NIH). The contract is for the delivery of PathHunter HTR2A GPCR internalization...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $20,830.00 firm-fixed-price purchase order to Eurofins Discoverx Corporation, a foreign-owned for-profit organization, for the provision of PATHHUNTER CHO-K1 DRD3 ARRESTIN CELL LINE and U2OS DRD3 ARRESTIN CELL LINE. This award is not associated with any set-aside program. Eurofins Discoverx Corporation is a leading provider of innovative cell-based assays...
The Department of Health and Human Services' National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $20,446 purchase order to Eurofins Discoverx Corporation of Fremont, California. Under the firm fixed price contract, Eurofins will provide GPCRMAX PANEL services to NIH NINDS from August 2023 through December 2023. As a leading provider of drug discovery services, Eurofins will support NINDS's work to understand, treat, and prevent disorders of the brain...
This is a firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Eurofins Discoverx Corporation, a foreign-owned for-profit organization. The contract is for the provision of the PATHHUNTER DETECTION KIT, which is used exclusively with the PATHHUNTER CELL LINES from Eurofins Discoverx. The contract has a ceiling value of $24,831.22 and a period of performance ending...
This is a $19,386.28 firm fixed-price purchase order awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency under the U.S. Department of Health and Human Services, to Eurofins Discoverx Corporation, a foreign-owned for-profit organization. The contract is for assaying services to support NIAAA's research activities, with a completion date of August 27, 2024. Eurofins Discoverx Corporation is a provider of cell-based assays, reagents, and services for drug...
This is a federal contract award from the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Eurofins Discoverx Corporation, a foreign-owned for-profit organization. The contract is for $301,894.16 in firm fixed-price services related to testing lead compounds for additional characterization and reagent development. The contract does not have a set-aside designation. Eurofins Discoverx Corporation is a provider of innovative cell-based...
This firm fixed-price purchase order for $30,778.40 was awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Eurofins Discoverx Products, LLC. The contract is to provide one PathHunter detection kit (PN 93-0001XL) to support NCATS' high-throughput screening efforts for GPR151, a target related to pain and addiction under the NIH HEAL (Helping to End Addiction Long-term) Initiative. Eurofins Discoverx Products was...
The Department of Health and Human Services' National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $20,446.64 firm fixed price purchase order to Eurofins Discoverx Corporation of Fremont, California. The purchase order is for GPCRMAX PANEL services and will be performed between June 26, 2023 and September 30, 2023 in Fremont. The National Institute of Neurological Disorders and Stroke supports research on brain and nervous system disorders to reduce...